APLS
Apellis Pharmaceuticals Inc.
$23.49
+$0.48(+2.09%)
65
Overall
40
Value
90
Tech
--
Quality
Market Cap
$3.01B
Volume
1.55M
52W Range
$16.10 - $35.72
Target Price
$37.25
Key Metrics Overview
| Market Cap | $3.01B | P/E Ratio | N/A |
| 52W High | $35.72 | 52W Low | $16.10 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | 43.4% | 52W Position | 37.7% |
| Overall Score | 65 | Value Score | 40 |
| Quality Score | -- | Technical Score | 90 |
Growth Analysis
| EPS Current Est | $-0.64 | EPS Next Est | $-0.93 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | APLS | $23.49 | +2.1% | 1.55M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Apellis Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW